1
|
Chou YE, Hsieh MJ, Wang SS, Lin CY, Chen YY, Ho YC, Yang SF. The impact of receptor of advanced glycation end-products polymorphisms on prostate cancer progression and clinicopathological characteristics. J Cell Mol Med 2021; 25:10761-10769. [PMID: 34708514 PMCID: PMC8581310 DOI: 10.1111/jcmm.17025] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Revised: 10/12/2021] [Accepted: 10/15/2021] [Indexed: 12/12/2022] Open
Abstract
The receptor for advanced glycation end products (RAGE) overexpression was suggested to be associated with prostate cancer development and poor prognosis. In this study, we focused on the correlations between the clinicopathological characteristics and susceptibility of prostate cancer and RAGE single-nucleotide polymorphisms (SNPs). In 579 prostate cancer patients, the RAGE SNPs rs1800625, rs1800624, rs2070600 and rs184003 in patients with or without grade group upgrade were analysed with real-time polymerase chain reaction. The results demonstrated that the prostate cancer patients who carried the RAGE SNPs rs2070600 'GA' genotypic variants were significantly associated with lower risk to develop grade group upgrade. Moreover, patients with the RAGE rs1800625 'TC + CC' genotypic variants were associated with higher risk of perineural invasion. In 343 prostate cancer patients who carried the RAGE rs1800625 'TC + CC' genotype without grade group upgrade were correlated with higher risk of biochemical recurrence and perineural invasion. In the analysis of TCGA database, significant differences of the RAGE mRNA level were found between the normal controls and prostate cancer patients (p < 0.0001), and the pathologic stage N1 and N0 patients (p = 0.0027). The prostate cancer patients with high RAGE expression were associated with lower overall survival rate (p = 0.025). In conclusion, our results have revealed that the RAGE SNPs rs2070600 and rs1800625 were associated with the grade group upgrade of prostate cancer and clinical status. The RAGE polymorphisms may provide as a pivotal predictor to evaluate prostate cancer disease progression and prognosis.
Collapse
Affiliation(s)
- Ying-Erh Chou
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.,Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.,Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan
| | - Ming-Ju Hsieh
- Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan.,College of Medicine, National Chung Hsing University, Taichung, Taiwan.,Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan
| | - Shian-Shiang Wang
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.,Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.,Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan
| | - Chia-Yen Lin
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.,Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan
| | - Yen-Yu Chen
- Department of Medical Applied Chemistry, Chung Shan Medical University, Taichung, Taiwan
| | - Yung-Chuan Ho
- Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.,Department of Medical Applied Chemistry, Chung Shan Medical University, Taichung, Taiwan
| | - Shun-Fa Yang
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.,Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan
| |
Collapse
|
2
|
Bedoui SA, Barbirou M, Stayoussef M, Dallel M, Mokrani A, Makni L, Mezlini A, Bouhaouala-Zahar B, Yacoubi-Loueslati B, Almawi WY. Identification of novel advanced glycation end products receptor gene variants associated with colorectal cancer in Tunisians: A case-control study. Gene 2020; 754:144893. [PMID: 32544495 DOI: 10.1016/j.gene.2020.144893] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2020] [Revised: 06/02/2020] [Accepted: 06/08/2020] [Indexed: 12/14/2022]
Abstract
A central role for advanced glycation end products (AGE) and their receptor (RAGE) in the pathogenesis of multiple cancer types, including colorectal cancer (CRC) was reported. We investigated the association between CRC and rs2853807, rs77170610, rs184003, rs1035798, rs2070600, rs1800684, rs1800624, and rs1800625 RAGE gene (AGER) polymorphic variants. Study subjects comprised 293 CRC patients [186 colon cancer (CC) and 107 rectal cancer (RC)] patients), and 264 age-, gender-, BMI-, and ethnicity-matched controls. Minor allele frequency (MAF) of rs77170610 and rs1800625 were significantly lower, while MAF of rs1035798 was significantly higher in CRC patients compared to control subjects, which was associated with reduced and increased risk of CRC, respectively; MAF of the remaining variants was comparable between CRC patients and controls. Significant difference in the distribution of rs2853807 and rs77170610 genotypes was seen between CRC patients and controls, with both variants associated with decreased risk of CRC. Comparison of the distribution of minor allele-carrying genotypes in CC and RC patient subgroups revealed lack of significant difference in the distribution of these genotypes between the patient subgroups. In view of the lack of LD between rs2853807 and rs77170610 with other variants, six-locus (rs184003, rs1035798, rs2070600, rs1800684, rs1800624, rs1800625) haplotypes were constructed. Haplotype analysis did not identify any specific 6-locus AGER haplotype associated with CRC. In conclusion, AGER gene rs2853807 and rs77170610 variants rs77170610 are associated with altered risk of CRC in Tunisians, but with no discrimination between CC and RC types.
Collapse
Affiliation(s)
- Sinda A Bedoui
- Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology Pathologies and Biomarkers, El Manar University, Tunis LR16ES05, Tunisia
| | - Mouadh Barbirou
- Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology Pathologies and Biomarkers, El Manar University, Tunis LR16ES05, Tunisia; Laboratory of Venoms and Therapeutic Molecules, Pasteur Institute of Tunis, Tunisia
| | - Mouna Stayoussef
- Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology Pathologies and Biomarkers, El Manar University, Tunis LR16ES05, Tunisia
| | - Meriem Dallel
- Laboratory of Human Genome and Multifactorial Diseases (LR12ES07), University of Monastir, Monastir, Tunisia
| | - Amina Mokrani
- Salah Azaiez Oncology Institute, Avenue 9 Avril, 1006, Bab Saadoun, Tunis, Tunisia
| | - Lamia Makni
- Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology Pathologies and Biomarkers, El Manar University, Tunis LR16ES05, Tunisia
| | - Amel Mezlini
- Salah Azaiez Oncology Institute, Avenue 9 Avril, 1006, Bab Saadoun, Tunis, Tunisia
| | - Balkiss Bouhaouala-Zahar
- Laboratory of Venoms and Therapeutic Molecules, Pasteur Institute of Tunis, Tunisia; Medical School of Tunis, University of Tunis El Manar, 15 rue Djebel Lakhdhar, La Rabta, 1007 Tunis, Tunisia
| | - Besma Yacoubi-Loueslati
- Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology Pathologies and Biomarkers, El Manar University, Tunis LR16ES05, Tunisia
| | - Wassim Y Almawi
- Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology Pathologies and Biomarkers, El Manar University, Tunis LR16ES05, Tunisia; College of Health Sciences, Abu Dhabi University, Abu Dhabi, United Arab Emirates.
| |
Collapse
|
3
|
Chhipa AS, Borse SP, Baksi R, Lalotra S, Nivsarkar M. Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications. Pathol Res Pract 2019; 215:152643. [DOI: 10.1016/j.prp.2019.152643] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/28/2019] [Revised: 08/30/2019] [Accepted: 09/15/2019] [Indexed: 12/13/2022]
|
4
|
Ghafouri-Fard S, Noroozi R, Musavi M, Taheri M. Association analysis between genomic variants within advanced glycation end product specific receptor ( AGER) gene and risk of breast cancer in Iranian women. Heliyon 2019; 5:e02542. [PMID: 31667394 PMCID: PMC6812209 DOI: 10.1016/j.heliyon.2019.e02542] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2019] [Revised: 05/04/2019] [Accepted: 09/26/2019] [Indexed: 12/31/2022] Open
Abstract
The advanced glycation end product specific receptor (AGER) gene codes for a cell surface receptor which is one of the immunoglobulin superfamily members. This gene has a number of single nucleotide polymorphisms (SNPs) whose variants are associated with altered function of the encoded protein. In the current project, we examined association between rs184003 and rs1800625 SNPs and susceptibility to breast cancer in an Iranian population. The current study excludes participation of rs184003 AGER variant in conferring cancer risk. However, for the rs1800625, based on the calculated P value, the results should be assessed in larger cohorts. Primarily, the rs1800625 SNP was associated with breast cancer risk in dominant model (OR (95% CI) = 1.79 (1.03–3.11)), but after correction for multiple comparisons it did not reach the level of significance (adjusted P value = 0.07). The other SNP was not associated with breast cancer risk in any inheritance model. Haplotype analyses revealed a trend toward association between the GC haplotype (rs184003 and rs1800625 respectively) and risk of breast cancer (OR (95% CI) = 1.77 (1.09–2.88), adjusted P value = 0.08)). The current study excludes participation of rs184003 AGER variants in conferring cancer risk. However, for the rs1800625, based on the calculated P value, the results should be assessed in larger cohorts.
Collapse
Affiliation(s)
- Soudeh Ghafouri-Fard
- Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Rezvan Noroozi
- Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Mehrnoosh Musavi
- Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
| | - Mohammad Taheri
- Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| |
Collapse
|
5
|
Xu Y, Lu Z, Shen N, Wang X. Association of RAGE rs1800625 Polymorphism and Cancer Risk: A Meta-Analysis of 18 Case-Control Studies. Med Sci Monit 2019; 25:7026-7034. [PMID: 31534114 PMCID: PMC6765339 DOI: 10.12659/msm.916260] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Background Accumulating evidence suggests that the rs1800625 polymorphism in RAGE promoter region might be associated with cancer risk; however, data from different studies show conflicting results. Here, a meta-analysis was conducted to evaluate the associations between RAGE rs1800625 polymorphism and cancer risk. Material/Methods We searched Embase (Excerpt Medica Database), PubMed, and CNKI (Chinese National Knowledge Infrastructure) databases until March 15, 2019 to identify potential studies for the meta-analysis. Results Eighteen eligible studies were included in the current meta-analysis, representing 6246 cases and 6819 controls. Pooled analysis showed positive correlation between the RAGE rs1800625 polymorphism and susceptibility of cancer in recessive genetic model [CC versus TC+TT: odds ratio (OR)=1.397, 95% confidence interval (CI): 1.031–1.894, P=0.031]. Subgroup analysis revealed this association in the Asian, but not Caucasian population, and this correlation was not detected in either breast or lung cancer. Sensitivity analysis indicated unstable results, which should be interpreted with caution. No publication bias was observed. Conclusions In conclusion, the RAGE rs1800625 polymorphism was associated with increased overall cancer risk in Asians in recessive genetic model. However, large-scale and well-designed studies in different populations and diverse cancer types are needed for a precise conclusion.
Collapse
Affiliation(s)
- Yuzhong Xu
- Department of Clinical Laboratory, Shenzhen Baoan Hospital, Southern Medical University, Shenzhen, Guangdong, China (mainland)
| | - Zhenhua Lu
- Department of Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China (mainland).,Hubei Province Academy of Traditional Chinese Medicine, Wuhan, Hubei, China (mainland)
| | - Na Shen
- Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science, Wuhan, Hubei, China (mainland)
| | - Xiong Wang
- Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science, Wuhan, Hubei, China (mainland)
| |
Collapse
|
6
|
Yun X, Bai Y, Li Z, Wang D, Zhu Y, Jing C. rs895819 in microRNA-27a increase stomach neoplasms risk in China: A meta-analysis. Gene 2019; 707:103-108. [PMID: 31054359 DOI: 10.1016/j.gene.2019.04.061] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2019] [Revised: 04/19/2019] [Accepted: 04/22/2019] [Indexed: 12/25/2022]
Abstract
BACKGROUND Across the globe, gastric cancer is a significant public health problem. This meta-analysis was conducted to investigate the association of microRNA-27a (miRNA-27a) rs895819 with gastric cancer risk. METHODS The search of databases updated on October 10, 2018 included Pubmed, Embase, Cochrane Library and Web of science. Odds ratio (ORs) and 95% confidence interval (CIs) were calculated to assess the risk of tumor. RESULTS Overall meta-analysis suggested the miRNA-27a rs895819 was not related to the gastric carcinogenesis among all model including allele contrast (G vs A, pooled OR: 1.096, 95% CI: 0.962-1.249, P = 0.196), codominant model (GG vs AA, pooled OR: 1.124, 95% CI: 0.794-1.592, P = 0.590; AG vs AA, pooled OR: 1.101, 95% CI: 0.966-1.217, P = 0.060), dominant model (AG + GG vs AA, pooled OR: 1.123, 95% CI: 0.964-1.307, P = 0.136) and recessive model (GG vs AG + AA, pooled OR: 0.927, 95% CI: 0.673-1.278, P = 0.644). Interestingly, among different ethnicity group, significant relation between rs895819 and gastric cancer was observed in co-dominant model among Chinese population (AG vs AA, pooled OR: 1.158, 95% CI: 1.038-1.291, P = 0.008) but not some regions of European population (AG vs AA, pooled OR: 0.852, 95% CI: 0.632-1.148, P = 0.179). CONCLUSIONS Our results find that rs895819 contributed to occurrence of gastric cancer in co-dominant model in Chinese population.
Collapse
Affiliation(s)
- Xiaojing Yun
- The Second People's Hospital of Liaocheng, Linqing, Shandong Province 252600, PR China
| | - Yuhuan Bai
- The Second People's Hospital of Liaocheng, Linqing, Shandong Province 252600, PR China
| | - Zhihui Li
- The Second People's Hospital of Liaocheng, Linqing, Shandong Province 252600, PR China
| | - Dongmei Wang
- The Second People's Hospital of Liaocheng, Linqing, Shandong Province 252600, PR China
| | - Yusen Zhu
- The Second People's Hospital of Liaocheng, Linqing, Shandong Province 252600, PR China
| | - Changchun Jing
- The Second People's Hospital of Liaocheng, Linqing, Shandong Province 252600, PR China.
| |
Collapse
|
7
|
Chen P, Bai Y, Li Y, Yuan Y, Cheng Y, Pang J, Zhu H, Chen C. Association between polymorphisms of MIR17HG and risk of colorectal cancer in the Chinese Han population. Mol Genet Genomic Med 2019; 7:e667. [PMID: 30941921 PMCID: PMC6565593 DOI: 10.1002/mgg3.667] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2018] [Revised: 02/13/2019] [Accepted: 03/08/2019] [Indexed: 02/06/2023] Open
Abstract
Background Colorectal cancer is the third most common cancer worldwide. Recently, an increasing number of evidences suggest that genetic susceptibility plays an important role in the occurrence of colorectal cancer. This study aimed to better understand the influence of MIR17HG polymorphisms on colorectal cancer susceptibility in the Chinese Han population. Methods We recruited 514 patients with colorectal cancer and 510 healthy controls to investigate the association between polymorphisms of MIR17HG and risk of colorectal cancer in the Chinese Han population. Genotyping was performed with the Agena MassARRAY platform. We used the χ2 test to compare the distributions of single nucleotide polymorphisms (SNPs) allele and genotypes frequencies between cases and controls. Odds ratios and 95% confidence intervals were calculated by logistic regression analysis to evaluate the association under genetic models. Linkage disequilibrium between the five SNPs was assessed using the Haploview software. Results Overall analysis found that rs7336610 and rs1428 and haplotype CTAGA were significantly associated with increased risk of colorectal cancer. However, we found rs7318578 was associated with a decreased risk of colorectal cancer in the dominant model. Stratification analysis showed that rs7336610, rs7318578, and rs1428 were also associated with rectal cancer risk. Gender stratification analysis found that rs7336610, rs7318578, rs17735387, and rs1428 were significantly associated with colorectal cancer risk in males. Conclusion In conclusion, this study indicated that the polymorphisms of MIR17HG were associated with colorectal cancer risk. Therefore, our findings may provide new insights into the development of colorectal cancer. Further association and functional studies are of great importance to confirm these results and to define the potential biological mechanism of colorectal cancer.
Collapse
Affiliation(s)
- Peng Chen
- The National Engineering Research Centre for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, P.R. China.,Institution of Basic Medical Science, Xi'an Medical University, Xi'an, P.R. China
| | - Yuwei Bai
- The National Engineering Research Centre for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, P.R. China
| | - Yaru Li
- The National Engineering Research Centre for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, P.R. China
| | - Yuemin Yuan
- The National Engineering Research Centre for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, P.R. China
| | - Yimin Cheng
- The National Engineering Research Centre for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, P.R. China
| | | | - Hongli Zhu
- The National Engineering Research Centre for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, P.R. China
| | - Chao Chen
- The National Engineering Research Centre for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, P.R. China
| |
Collapse
|